Cannaderno

Full Description of the Application - Cannaderno

Cannaderno is an innovative digital tool developed to assist healthcare professionals, patients and pet owners in monitoring therapeutic treatments with medicines based on Cannabis sativa L. With the aim of providing effective and personalized monitoring, the application allows the recording of essential information in an interactive diary, optimizing the effectiveness of the prescribed treatment.

Users can add relevant data, such as symptoms, adverse effects, dosages, and administration times, facilitating detailed monitoring of treatment progress. Furthermore, Cannaderno enables the safe and organized use of this information for scientific research purposes, contributing to advancement in the field of cannabinoid medicine.

The legality of the therapeutic use of Cannabis sativa L. in Brazil is supported by the Anvisa Collegiate Board, as established in Ordinance SVS/MS No. 344/98, which allows the import of products containing cannabidiol (CBD) and tetrahydrocannabinol (THC) upon prescription medical device for your own use.

The application highlights that its use does not replace specialized medical monitoring and recommends that all actions related to treatment be discussed with a trusted doctor. It is developed under the technical supervision of Dr. Caroline Helena da Silva Campagnone (CRMV/SP 39.770) and Dr. Anna Carolina Golçalves Tames Zambrana (CRM/SP 197.219).